National Health Investors, Inc. (NHI) Income Statement Analysis

See more : PT Jaya Konstruksi Manggala Pratama Tbk (JKON.JK) Income Statement Analysis – Financial Results

Complete financial analysis of National Health Investors, Inc. (NHI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of National Health Investors, Inc., a leading company in the REIT – Healthcare Facilities industry within the Real Estate sector.

You may be interested

PT Hasnur Internasional Shipping Tbk (HAIS.JK) Income Statement Analysis – Financial Results
Formosa Pharmaceuticals, Inc. (6838.TWO) Income Statement Analysis – Financial Results
Vo2 Cap Holding AB (publ) (VO2.ST) Income Statement Analysis – Financial Results
PT Bank JTrust Indonesia Tbk (BCIC.JK) Income Statement Analysis – Financial Results
Australian Agricultural Company Limited (AAYYY) Income Statement Analysis – Financial Results

National Health Investors, Inc. (NHI)

Industry: REIT - Healthcare Facilities

Sector: Real Estate

Website: https://www.nhireit.com

About National Health Investors, Inc.

Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Metric	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995	1994	1993	1992	1991
Revenue	319.84M	278.19M	298.72M	332.81M	318.08M	294.61M	278.66M	248.50M	228.99M	177.51M	117.83M	96.95M	82.70M	78.40M	64.22M	63.01M	62.31M	150.72M	157.38M	155.56M	162.49M	171.78M	139.17M	147.51M	131.16M	102.29M	110.18M	99.43M	87.90M	71.40M	49.50M	39.40M	7.90M
Cost of Revenue	11.51M	9.79M	11.64M	9.65M	5.80M	1.17M	960.00K	1.01M	985.00K	620.00K	616.00K	771.00K	0.00	2.00M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Gross Profit	308.32M	268.41M	287.08M	323.16M	312.28M	293.45M	277.70M	247.49M	228.00M	176.89M	117.21M	96.18M	82.70M	76.39M	64.22M	63.01M	62.31M	150.72M	157.38M	155.56M	162.49M	171.78M	139.17M	147.51M	131.16M	102.29M	110.18M	99.43M	87.90M	71.40M	49.50M	39.40M	7.90M
Gross Profit Ratio	96.40%	96.48%	96.10%	97.10%	98.18%	99.60%	99.66%	99.59%	99.57%	99.65%	99.48%	99.20%	100.00%	97.44%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Research & Development	0.00	0.23	0.38	0.57	0.50	0.52	0.58	0.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
General & Administrative	19.72M	25.32M	19.34M	14.56M	13.91M	12.86M	12.71M	10.20M	10.98M	9.32M	10.04M	8.57M	8.03M	8.85M	7.21M	5.18M	5.66M	5.34M	4.31M	3.49M	3.14M	2.43M	3.30M	3.46M	3.28M	3.89M	3.70M	3.69M	3.40M	0.00	0.00	0.00	0.00
Selling & Marketing	100.00K	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
SG&A	19.82M	25.32M	19.34M	14.56M	13.91M	12.86M	12.71M	10.20M	10.98M	9.32M	10.04M	8.57M	8.03M	8.85M	7.21M	5.18M	5.66M	5.34M	4.31M	3.49M	3.14M	2.43M	3.30M	3.46M	3.28M	3.89M	3.70M	3.69M	3.40M	0.00	0.00	0.00	0.00
Other Expenses	109.71M	99.92M	134.35M	84.68M	78.37M	71.35M	67.17M	1.66M	53.16M	38.08M	3.31M	4.85M	12.81M	11.05M	7.37M	8.55M	2.36M	95.15M	116.67M	96.24M	101.89M	127.25M	115.83M	81.79M	99.86M	47.87M	53.31M	49.21M	0.00	0.00	0.00	0.00	0.00
Operating Expenses	129.53M	125.24M	153.69M	99.23M	92.27M	85.37M	80.84M	70.77M	65.13M	48.01M	30.76M	25.92M	20.84M	19.90M	14.58M	13.73M	8.01M	100.50M	120.98M	99.73M	105.03M	129.67M	119.13M	85.25M	103.14M	51.76M	57.01M	52.90M	-7.60M	-10.50M	-8.20M	-7.10M	-1.60M
Cost & Expenses	143.36M	135.03M	165.33M	108.88M	98.07M	85.37M	80.84M	70.77M	65.13M	48.01M	30.76M	25.92M	20.84M	19.90M	14.58M	13.73M	8.01M	100.50M	120.98M	99.73M	105.03M	129.67M	119.13M	85.25M	103.14M	51.76M	57.01M	52.90M	-7.60M	-10.50M	-8.20M	-7.10M	-1.60M
Interest Income	-2.65M	44.92M	50.81M	52.88M	56.30M	0.00		18.00K			0.00	0.00	0.00	6.74M	1.24M	6.49M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest Expense	55.51M	44.92M	50.81M	52.88M	56.30M	49.06M		43.11M			9.23M	3.49M	3.85M	1.55M	85.00K	308.00K	4.63M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation & Amortization	69.97M	140.03M	165.45M	106.65M	99.16M	89.79M	79.96M	86.12M	53.16M	40.69M	20.10M	16.58M	11.99M	10.99M	8.62M	7.94M	11.73M	11.81M	12.60M	14.45M	15.38M	16.38M	14.66M	14.17M	11.49M	8.96M	8.04M	6.83M	6.10M	5.30M	5.20M	4.70M	1.20M
EBITDA	251.49M	151.99M	212.99M	303.95M	296.83M	280.59M	264.99M	236.08M	179.36M	167.06M	107.63M	87.66M	76.05M	68.15M	57.57M	53.34M	82.87M	66.31M	49.38M	55.29M	72.84M	247.76M	233.19M	77.60M	91.44M	60.18M	61.21M	54.48M	101.60M	87.20M	62.90M	51.20M	10.70M
EBITDA Ratio	78.63%	54.64%	71.30%	91.33%	93.32%	95.24%	95.09%	95.00%	94.00%	93.17%	91.23%	90.42%	71.48%	82.01%	81.52%	80.51%	84.55%	32.83%	20.37%	37.71%	44.83%	31.39%	25.71%	52.61%	30.69%	58.83%	55.55%	54.79%	115.59%	122.13%	127.07%	129.95%	135.44%
Operating Income	178.79M	81.11M	132.19M	220.80M	220.01M	209.24M	197.82M	177.73M	163.86M	106.19M	77.84M	71.04M	61.86M	58.50M	49.64M	49.27M	54.30M	50.23M	36.40M	55.83M	57.46M	42.11M	20.04M	62.26M	28.02M	50.53M	53.17M	46.53M	95.50M	81.90M	57.70M	46.50M	9.50M
Operating Income Ratio	55.90%	29.16%	44.25%	66.34%	69.17%	71.02%	70.99%	71.52%	71.56%	59.82%	66.07%	73.27%	74.80%	74.62%	77.30%	78.20%	87.14%	33.32%	23.13%	35.89%	35.36%	24.51%	14.40%	42.21%	21.37%	49.40%	48.26%	46.80%	108.65%	114.71%	116.57%	118.02%	120.25%
Total Other Income/Expenses	-44.41M	-80.22M	-15.04M	-33.54M	-59.56M	-49.94M	-38.45M	-74.13M	-66.10M	-26.44M	-28.49M	0.00	7.95M	-707.00K	0.00	0.00	-3.48M	8.44M	16.93M	-4.89M	0.00	-185.02M	-218.78M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Income Before Tax	134.38M	65.50M	111.97M	185.31M	160.45M	154.33M	159.37M	153.47M	149.61M	103.05M	79.50M	74.66M	81.13M	69.42M	64.23M	57.51M	67.64M	62.95M	53.71M	67.52M	0.00	47.19M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Income Before Tax Ratio	42.02%	23.55%	37.48%	55.68%	50.44%	52.39%	57.19%	61.76%	65.33%	58.05%	67.47%	77.01%	98.10%	88.55%	100.01%	91.28%	108.55%	41.76%	34.13%	43.41%	0.00%	27.47%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Income Tax Expense	0.00	42.44M	49.78M	49.94M	56.29M	-9.17M	46.32M	749.00K	-707.00K	24.67M	-17.13M	-12.53M	-19.27M	-10.92M	-14.59M	-8.24M	-42.13M	-18.83M	-17.65M	-472.00K	13.66M	11.83M	21.19M	29.70M	-24.85M	-18.42M	-22.22M	-19.52M	45.80M	43.00M	33.30M	33.20M	7.40M
Net Income	135.65M	23.06M	62.19M	135.37M	104.16M	154.33M	159.37M	151.54M	148.86M	101.61M	106.18M	90.73M	81.13M	69.42M	64.23M	57.51M	96.44M	69.23M	54.41M	56.38M	43.81M	30.79M	-63.00K	33.72M	53.62M	69.65M	75.39M	67.16M	49.70M	38.90M	24.40M	13.30M	2.10M
Net Income Ratio	42.41%	8.29%	20.82%	40.67%	32.75%	52.39%	57.19%	60.98%	65.01%	57.24%	90.12%	93.58%	98.10%	88.55%	100.01%	91.28%	154.76%	45.93%	34.57%	36.24%	26.96%	17.92%	-0.05%	22.86%	40.88%	68.08%	68.42%	67.55%	56.54%	54.48%	49.29%	33.76%	26.58%
EPS	3.13	0.52	1.36	3.03	2.40	3.68	3.90	3.88	3.96	3.04	3.74	3.26	2.93	2.51	2.33	2.08	3.48	2.50	1.96	2.05	1.58	1.10	0.00	1.31	2.13	2.72	3.01	2.92	2.63	2.35	1.95	1.60	0.29
EPS Diluted	3.13	0.51	1.36	3.03	2.38	3.67	3.87	3.87	3.95	3.04	3.74	3.26	2.92	2.50	2.32	2.07	3.47	2.49	1.96	2.03	1.57	1.10	0.00	1.31	2.13	2.69	2.92	2.80	2.49	2.28	1.95	1.60	0.29
Weighted Avg Shares Out	43.39M	44.77M	45.71M	44.70M	43.42M	41.94M	40.89M	39.01M	37.60M	33.38M	28.36M	27.81M	27.72M	27.66M	27.59M	27.71M	27.70M	27.74M	27.70M	27.26M	26.73M	26.45M	24.47M	24.38M	24.37M	24.96M	24.42M	21.94M	16.39M	13.28M	12.51M	7.48M	7.24M
Weighted Avg Shares Out (Dil)	43.39M	44.79M	45.73M	44.70M	43.70M	42.09M	41.15M	39.16M	37.64M	33.42M	28.40M	27.84M	27.79M	27.73M	27.62M	27.73M	27.78M	27.78M	27.83M	27.53M	26.99M	26.85M	24.47M	24.56M	24.37M	28.69M	25.17M	27.24M	17.31M	13.68M	12.51M	7.48M	7.24M

Here's Why National Health Investors (NHI) is Poised for a Turnaround After Losing -10.18% in 4 Weeks

October 15, 2024zacks.com

The heavy selling pressure might have exhausted for National Health Investors (NHI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the...

Rate Cut Rethink

October 13, 2024seekingalpha.com

U.S. equity markets extended gains to a fifth-straight week despite a continued upswell in benchmark interest rates, as investors weighed a solid start to earnings season against lukewarm inflation data. All eyes were on the Consumer Price Index report, which...

NHI Issues Investor Update

October 10, 2024accesswire.com

MURFREESBORO, TN / ACCESSWIRE / October 10, 2024 / National Health Investors, Inc. (NYSE:NHI) has issued an investor update which can be found at: NHI | Presentations and Webcasts (nhireit.com) Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a...

PLYM vs. NHI: Which Stock Is the Better Value Option?

October 8, 2024zacks.com

Investors interested in REIT and Equity Trust - Other stocks are likely familiar with Plymouth Industrial (PLYM) and National Health Investors (NHI). But which of these two companies is the best option for those looking for undervalued stocks?

NHI Announces Third Quarter 2024 Earnings Release and Conference Call Dates

October 3, 2024accesswire.com

MURFREESBORO, TN / ACCESSWIRE / October 3, 2024 / National Health Investors, Inc. (NYSE:NHI) announced details for the release of its results for the third quarter ended September 30, 2024. NHI plans to issue its earnings release after the market...

National Health Investors: From Struggles To Strength

September 29, 2024seekingalpha.com

National Health Investors has shown strong portfolio improvements, driven by increased senior housing occupancy and a recovering industry landscape. NHI's financial performance is robust, with double-digit FFO growth in Q2 and significant NOI expansion. The stock currently yields 4.3% with...